Importantly, treatment of chemoresistant CRC sublines with a neutralising Ab against PD‐L1 significantly attenuated sphere‐forming capacity (Figure 2K) and CSC marker expression (Figure 2L). This evidence concerns the gene CD274 and colorectal carcinoma.